Experimental data show that propolis and some of its components have anti-angiogenic activity against neoplastic cells, decreasing the activation of hypoxia-inducible factor 1 (HIF-1α), and hence reducing vascularization induced by VEGF and consequently suppressing tumor growth. The gene discussed is VEGFA; the disease is neoplasm.